Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.3 EUR | +0.98% | +2.00% | 0.00% |
06-26 | DSM-Firmenich Unit Issues EUR800 Million Bond | MT |
06-26 | DSM-Firmenich Issues ?800 Million Long-Term Bond | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 61.48 times its estimated earnings per share for the ongoing year.
- The company is highly valued given the cash flows generated by its activity.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Sector: Consumer Goods Conglomerates
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
0.00% | 29.77B | - | ||
+13.72% | 888B | D+ | ||
+1.75% | 244B | - | C | |
+25.86% | 175B | B | ||
+1.77% | 140B | B- | ||
+76.35% | 102B | B+ | ||
-8.80% | 71B | B | ||
-7.20% | 56.47B | C+ | ||
+102.95% | 34.71B | B- | ||
+24.99% | 33.2B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- DSFIR Stock
- ZX61 Stock
- Ratings DSM-Firmenich AG